Hong Kong-listed innovative drug ETF continues to lead the way.

Last week, the sectors of innovative drugs and AI computing power strengthened, related thematic ETFs rose sharply, including Huatai Bairui HS Innovation Drug ETF and 5 other Hong Kong stock innovative drug thematic ETFs which rose by more than 13%, with multiple artificial intelligence, communication, cloud computing and other thematic ETFs rising by more than 10%. Meanwhile, the performance of thematic ETFs in gaming, real estate, financial technology, etc. was relatively flat. Since the first batch of 10 science and technology innovation bond ETFs were listed on July 17th, they have seen large inflows of funds for two trading days, with a total net inflow of nearly 60 billion RMB, and the total scale has increased significantly from less than 29 billion RMB to over 88 billion RMB. In addition, securities, dividend low volatility and semiconductor thematic ETFs have also received incremental allocation funds.